Aims/Background The aim of this study was to evaluate the outcomes following open biliary bypass for benign biliary and pancreatic diseases.
Method Sixty-four patients (M: F=34:30) aged 15 to 89 years (median age: 54 years) underwent biliary bypass for benign diseases between 2001 and 2011. Indications for surgery were choledocholithiasis (n=18), chronic pancreatitis (n=18), iatrogenic bile duct injury (n=12), distal bile duct strictures (n=11), choledochal cyst (n=2) and other causes (n=3). Thirty-eight patients (60%) had prior surgical or endoscopic intervention.
Results Sixty hepaticojejunostomies and four choledochoduodenostomies were performed. Additional procedures during the same surgery included cholecystectomy (n=25), drainage of pseudocyst (n=4), gastroenterostomy (n=4), pancreatic biopsy (n=4), liver biopsy (n=4), cyst gastrostomy (n=2) and pancreatic necrosectomy (n=2). Postoperative complications were encountered in 12 patients – bile leak (n=2), bleeding (n=2), chest infection (n=2), MI (n =1), superficial surgical site infection (n=4) and superficial wound dehiscence (n=1). Three patients required further surgery–bile leak (n=1), bleeding (n=2). Two patients (3%) died of organ failure-one following biliary bypass for cholangitis; and one following ligation of a bleeding pseudo aneurysm. Five patients developed recurrent cholangitis requiring oral antibiotics.
Conclusion In the era of minimally invasive options, open biliary bypass remains a very effective, reliable and safe option in the management of benign conditions of the biliary system and pancreas.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.